314 related articles for article (PubMed ID: 10816321)
1. Role of INTERLEUKIN-6 in the pathogenesis of multiple myeloma.
Gadó K; Domján G; Hegyesi H; Falus A
Cell Biol Int; 2000; 24(4):195-209. PubMed ID: 10816321
[TBL] [Abstract][Full Text] [Related]
2. The role of interleukin-6 and interleukin-6/interleukin-6 receptor-alpha complex in the pathogenesis of multiple myeloma.
Barillé S; Bataille R; Amiot M
Eur Cytokine Netw; 2000 Dec; 11(4):546-51. PubMed ID: 11125296
[TBL] [Abstract][Full Text] [Related]
3. Cytokine network in human multiple myeloma.
Klein B; Bataille R
Hematol Oncol Clin North Am; 1992 Apr; 6(2):273-84. PubMed ID: 1582974
[TBL] [Abstract][Full Text] [Related]
4. Signalling and survival pathways in multiple myeloma.
Bommert K; Bargou RC; Stühmer T
Eur J Cancer; 2006 Jul; 42(11):1574-80. PubMed ID: 16797970
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 in multiple myeloma and related plasma cell dyscrasias.
Treon SP; Anderson KC
Curr Opin Hematol; 1998 Jan; 5(1):42-8. PubMed ID: 9515202
[TBL] [Abstract][Full Text] [Related]
6. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.
Lauta VM
Cancer; 2003 May; 97(10):2440-52. PubMed ID: 12733143
[TBL] [Abstract][Full Text] [Related]
7. Advances in the biology of multiple myeloma: therapeutic applications.
Anderson K
Semin Oncol; 1999 Oct; 26(5 Suppl 13):10-22. PubMed ID: 10528890
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 6 (IL-6) and its receptor: their role in plasma cell neoplasias.
Hirano T
Int J Cell Cloning; 1991 May; 9(3):166-84. PubMed ID: 2061619
[TBL] [Abstract][Full Text] [Related]
9. The role of human and viral cytokines in the pathogenesis of multiple myeloma.
Berenson JR; Sjak-Shie NN; Vescio RA
Semin Cancer Biol; 2000 Oct; 10(5):383-91. PubMed ID: 11100886
[TBL] [Abstract][Full Text] [Related]
10. Pathogenetic relation between monoclonal gammopathies of undetermined significance and multiple myeloma.
Greipp PR; Lust JA
Stem Cells; 1995 Aug; 13 Suppl 2():10-21. PubMed ID: 8520496
[TBL] [Abstract][Full Text] [Related]
11. Role of cytokines in multiple myeloma.
Anderson KC; Lust JA
Semin Hematol; 1999 Jan; 36(1 Suppl 3):14-20. PubMed ID: 9989484
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6.
Dezorella N; Pevsner-Fischer M; Deutsch V; Kay S; Baron S; Stern R; Tavor S; Nagler A; Naparstek E; Zipori D; Katz BZ
Exp Cell Res; 2009 Jul; 315(11):1904-13. PubMed ID: 19328780
[TBL] [Abstract][Full Text] [Related]
13. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
Alexandrakis MG; Passam FH; Boula A; Christophoridou A; Aloizos G; Roussou P; Kyriakou DS
Ann Hematol; 2003 Jan; 82(1):19-23. PubMed ID: 12574959
[TBL] [Abstract][Full Text] [Related]
14. Activation of sphingosine kinase mediates suppressive effect of interleukin-6 on human multiple myeloma cell apoptosis.
Li QF; Wu CT; Duan HF; Sun HY; Wang H; Lu ZZ; Zhang QW; Liu HJ; Wang LS
Br J Haematol; 2007 Sep; 138(5):632-9. PubMed ID: 17686057
[TBL] [Abstract][Full Text] [Related]
15. Cytokine, cytokine receptors, transduction signals, and oncogenes in human multiple myeloma.
Klein B
Semin Hematol; 1995 Jan; 32(1):4-19. PubMed ID: 7878477
[No Abstract] [Full Text] [Related]
16. Novel therapeutic strategies targeting growth factor signalling cascades in multiple myeloma.
Yasui H; Hideshima T; Richardson PG; Anderson KC
Br J Haematol; 2006 Feb; 132(4):385-97. PubMed ID: 16412014
[TBL] [Abstract][Full Text] [Related]
17. [Study of IL-6 signal transduction pathway in a human multiple myeloma cell line--Sko-007].
Song L; Li Y; Shen B
Zhonghua Xue Ye Xue Za Zhi; 2000 Nov; 21(11):569-71. PubMed ID: 11225245
[TBL] [Abstract][Full Text] [Related]
18. [Signal transduction and biological function of IL-6 in a human myeloma cell line-XG-7].
Song L; Shen B
Zhonghua Yi Xue Za Zhi; 2000 Nov; 80(11):845-8. PubMed ID: 11218881
[TBL] [Abstract][Full Text] [Related]
19. Targeting the phosphatidylinositol 3-kinase pathway in multiple myeloma.
Younes H; Leleu X; Hatjiharissi E; Moreau AS; Hideshima T; Richardson P; Anderson KC; Ghobrial IM
Clin Cancer Res; 2007 Jul; 13(13):3771-5. PubMed ID: 17606706
[TBL] [Abstract][Full Text] [Related]
20. Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells.
Wang YD; De Vos J; Jourdan M; Couderc G; Lu ZY; Rossi JF; Klein B
Oncogene; 2002 Apr; 21(16):2584-92. PubMed ID: 11971193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
